Dr Sherwin’s scientific background is in biochemistry with an emphasis on osteoarthritis, tissue engineering and cell culture. She has wide experience in both cell and molecular biology techniques. Dr Sherwin has excellent writing skills and has published several peer-reviewed journal articles and scientific reports as both lead author and supporting author during her post-doctoral work in the United Kingdom and New Zealand. Dr Sherwin has been a full-time editor with Edanz Editing since 2002. During that time, she has edited over 3000 manuscripts in the Health and Life Sciences for Japanese and Chinese authors, with a wide range of research fields and target journals.

Dr Fee is a professor of chemical engineering at the University of Canterbury, with expertise particularly in biotechnology, biochemical and biomolecular engineering. His PhD topic was on blood flow disturbances in the carotid artery and their links to atherosclerosis. He was a post-doctoral fellow at the University of Waterloo, Canada, in 1989/90, working on membrane ultrafiltration. He then returned to NZ as a lecturer at the University of Waikato, and a biochemical engineer at the Meat Industry Research Institute of New Zealand (MIRINZ). A full-time lecturer at the University of Waikato from 1996, he was head of the Department of Materials and Process Engineering from 2003 until 2006, when he took up a chair in chemical engineering at the University of Canterbury. Dr Fee has a wide range of experience in protein purification, protein PEGylation, membrane separations and process chromatography, and has worked in controlled drug delivery, microencapsulation and high-value dairy protein purifications. He is Director of the Biomolecular Interactions Centre at the University of Canterbury and has expertise in surface plasmon resonance. Dr Fee has published over 160 journal articles, book chapters, conference papers, patents and industrial research reports across a wide range of chemical engineering topics. Dr Fee began working with Edanz Editing as an editor in fields associated with chemical engineering and biotechnology in 2008.

Dr Creasey is a senior post-doctoral fellow in the laboratory of Dr Paul Hunt, University of Edinburgh (genetics of artemisinin drug resistance in a rodent malaria model). Her special interests have been in the field of tropical medicine and tropical parasitic diseases, with training in the epidemiological aspects of disease. Her field experience in serology and microbiology involved a number of anti-parasitic drug trials in Africa. Later in Edinburgh, genetics and molecular biology were focused on. Dr Creasey has the ability to communicate science in clear, unambiguous language. During her career she has edited journal articles and PhD theses for scientists from China, Thailand, Sri Lanka, Saudi Arabia, and most African countries. Dr Creasey joined Edanz Editing as an editor in 2007.

Dr Curtis’s PhD thesis was entitled “Neural Progenitor Cells in Huntington’s Disease Human Brain.” He is currently a Post-doctoral Research Fellow studying neurodegenerative disorders. Dr Curtis has authored many published reports in several leading international journals including the cover article for an issue of Science in 2007. He has given invited lectures in several countries, presenting topics associated with the field of neurology. Dr Curtis began editing for Edanz Editing in early 2006 and works in a very broad area of the biomedical sciences, applying his extensive knowledge of laboratory and imaging procedures.

From 1993 to 2006, Dr Helliwell held positions in several research organizations as a Research Fellow in the areas of Anatomy with Radiology, Pharmacology, Neuroscience and Molecular Endocrinology. Dr Helliwell is a highly regarded and well published (12 first authored reports and numerous abstracts) scientist in her field; as well she is an invited peer reviewer for many international journals. She has strong analytical skills that she brings to the editing of manuscripts for submission to peer-reviewed journals. She joined Edanz Editing in late 2006. Her fields of editing can best be described by the following areas of competence: basic molecular and cell biology techniques, in situ hybridization, cell and tissue culture, immunocytochemistry, immunohistochemistry, immunofluorescence, Western blotting and zymography, receptor autoradiography and receptor binding assays, mammalian neuroanatomy and neuroendocrinology.

Dr Devon is a biologist with a special interest in neuroscience and genetics. She is a graduate of the University of Cambridge, United Kingdom, and obtained her PhD in 1996 from the University of Edinburgh, UK, in the genetics of psychiatric illness. She undertook post-doctoral research on a rare, inherited form of Motor Neurone Disease (Lou Gehrig's Disease) in Vancouver, Canada, and then started her own research group back in Edinburgh, UK, investigating the genetics, cell biology and biochemistry of motor neurone disease. She is a co-founder of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh. Dr Devon has written over 50 research papers, book chapters, reviews and successful grant applications, and has peer-reviewed manuscripts for molecular biology journals. Dr Devon began working with Edanz Editing in 2008.

Dr David has conducted research in many areas, including inorganic chemistry, physical chemistry, and analytic chemistry. Her most recent research investigated the forensic use of isotope ratio mass spectrometry for the analysis of illicit drugs. Dr David is an experienced science communicator and editor, and received an award in the MacDiarmid Young Scientist of the Year competition (2007, New Zealand). She has also completed an internship with the United Nations Office on Drugs and Crime (Bangkok, Thailand). Dr David has presented at conferences and has peer-reviewed publications in the areas of physical, analytical, and forensic chemistry. Dr David began working as an editor with the Edanz Group in 2008.

Dr Smith’s PhD thesis was entitled “The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”. Dr Smith has been a Research Assistant at the Queen Mary, University of London’s Institute of Cellular and Molecular Sciences, where he focused on the biochemistry of diabetes and related metabolic disorders. He has also been a Research Fellow at the London Sport Institute, part of Middlesex University. Dr Smith has studied editing and design skills in relation to publication at the London School of Journalism, and is now a full-time medical writer. Dr Smith gained extensive experience in medical and scientific communications while employed at the internationally recognized agency Medicus International, where he worked on a range of medical communications projects for several well-known pharmaceutical companies. He joined the Edanz Group in 2006, where he is able to apply his wide research background and expertise in the medical communications sector in assisting clients to achieve their publication goals.

Dr Wright has been editing scientific manuscripts for non-native authors since 1997 and has been an editor for Edanz Editing since 2004. His scientific background is diverse, with the main scientific fields being in chemistry (organic, organometallic, inorganic and surface), semiconductors, biosensors (transducers, DNA and protein arrays) and nanotechnology. In 1996/7, Dr Wright was a Post-doctoral Fellow at The University of Tokyo, Japan, investigating novel catalytic pathways capable of generating ammonia under milder conditions than presently used in industry. As well as working for Edanz Editing, Dr Wright, now based in the UK, continues as a research scientist in the field of bionanosensors.

Dr Demarest received a BSc in Psychology and a PhD in Neurobiology and Behavior from the State University of New York at Stony Brook. Her work has focused on the neuroscience and genetics of a behavioral mouse model. From her research she has authored several peer-reviewed papers. She is currently a staff scientist at the Scripps Research Institute. She joined the Edanz Group as an editor in 2008.

Dr McGowan has won many awards during his career, including in 2003 the EU Marie Curie Post-doctoral Fellowship. He has worked in laboratories investigating the molecular mechanisms in Parkinson’s disease as well as those involved in Huntington’s disease, combining laser micro-dissection, microarray analysis and proteomics. Further study involved micro-array gene expression analysis of molecular processes occurring during normal aging and how these are affected by mental exercise. Dr McGowan has an in-depth knowledge of neurodegenerative diseases, neural function, marine zoology, molecular and cellular biology and protein biochemistry, along with extensive multi-disciplinary laboratory experience of contemporary and traditional techniques including proteomics, functional genomics and cell imaging. His excellent written and oral communication skills are demonstrated by several first author publications. From 2005 to October 2006, Dr McGowan was an Associate Editor at Nature Reviews Neuroscience before becoming a full-time editor for Edanz Editing. Dr McGowan is the Edanz Group Science Director.

McPherson's background is in chemistry. For her PhD, “Sulfur-substituted alkyl complexes of platinum and palladium,” she investigated the synthesis and properties of sulfur-substituted organoplatinum and organopalladium complexes. She has over 25 years' experience in scientific publishing, working mainly in the physical sciences and engineering. She has been an independent publishing and editorial consultant since 2002 and began working for the Edanz Group in 2009.

Dr Smith has worked as a research scientist investigating novel marine extracts with involvement in crop and food research. Dr Smith studied as a post-doctoral researcher at the CNRS Roscoff, France. As well, she has published several research papers in peer-reviewed journals, written numerous IP-protected/confidential reports, and presented at more than 20 international conferences. She is also a reviewer for several academic journals (Functional Plant Biology, Enzyme and Microbial Technology). Dr Smith’s areas of professional expertise for editing are biochemistry and biology, especially of plants, phycology (marine plants), fisheries science, and marine biology, and food and food technology. Dr Smith began working with Edanz Editing in 2007 and now works full time as a science copyeditor.

For three years, Dr Furness was a Post-doctoral Research Fellow at the Beatson Institute for Cancer Research, Glasgow, where she used extensive molecular genetic techniques to examine the factors influencing the growth of hematopoietic stem cells, with relevance to the development of cancers such as leukemia. Later Dr Furness was a researcher at Glasgow University where she analyzed the energetic requirements of seabirds, using field observations, analysis of radioisotopes from blood samples and metabolic monitoring of birds in respirometers. Dr Furness is a scientific editor with extensive experience of abstracting, indexing and editing scientific papers on a wide range of topics including general medicine, pharmacology and genetics, with personal experience of active scientific research and the publishing of research papers. From 1993 to 2007, Dr Furness was a Specialist Medical Indexer at Thomson Scientific. She began working with Edanz Editing in 2007.

Prof McKune is an Associate Professor in the Department of Biokinetics, Exercise and Leisure Sciences at the University of KwaZulu-Natal, South Africa. His PhD thesis examined immune and inflammatory responses to strenuous exercise. He is a South African National Research Foundation rated researcher and is a past co-leader of National Research Foundation Niche Area examining the effect of exercise on immune and inflammatory responses in healthy adults. Prof McKune’s research is currently supported by National Research Foundation and Medical Research Council competitive research grants. His research interests include the immune/inflammatory response to exercise with applications to the prevention and treatment of chronic diseases of lifestyle, and the promotion of optimal adaptation to strength and conditioning training. He has published 28 articles on topics including heart rate variability, hypertension, obesity, exercise-induced muscle damage, immune and inflammatory responses to exercise, and the impact of exercise on motor and cognitive function. Prof McKune began working with the Edanz Group in 2011.

Dr Kondejewski’s scientific background is in physiology, endocrinology, molecular biology, obstetrics, gynecology, and perinatology. She has a special interest in the genotypes and phenotypes associated with preterm labor and pregnancy pathologies. Dr Kondejewski has research skills including DNA/RNA isolation and manipulation, DNA sequencing and analysis, PCR, enzyme-linked immunosorbent assay (ELISA), cell culture, in situ hybridization, immunohistochemistry, and electron microscopy. Dr Kondejewski has published over 30 peer-reviewed articles, book chapters, and abstracts. She presently works as a grant writer and manuscript coordinator for publishing in high-impact journals. Dr Kondejewski began working as an editor for the Edanz Group in 2010.

Dr Laura Kuhar is a research scientist in the Precious and Base Metals Hydrometallurgy group of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Perth, Australia. Dr Kuhar has always displayed an interest in writing and is currently a reviewer for the Minerals Engineering journal and a former assistant editor of the De Beers Science and Engineering Review. She has published six internationally refereed papers, over 40 peer-reviewed industry reports or technical notes, and has presented at two international conferences. Her work experience has been in chemical, mechanical, mineral and metallurgical processing and fundamental chemical research. Dr Kuhar edits in a variety of fields and began work with the Edanz Group in 2010.

Dr Mahkdum was a Research Fellow at the University College London before becoming a Post-doctoral Research Fellow at the Scripps Institute at the University of California, San Diego, in California. Since 2000, Dr Makhdum has been a medical writer and editor holding various positions including Managing Editor at Elsevier in Oxford from 2005 to 2007. Dr Makhdum began as an editor with Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

Dr Dingley’s research is broadly in the area of biochemistry, with particular interest in characterizing protein structure and function. Dr Dingley has over 15 years' experience in publishing articles in international high-impact journals. He has written scientific book chapters, and is an editor on the editorial advisory board for the Biochemical Journal. Dr Dingley began as an editor for Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

Dr Clements has published 9 reports as first author in international peer-reviewed journals, such as Behavioral Neuroscience, General and Comparative Endocrinology, and Hormones and Behavior. He has written numerous professional reports and made over 25 presentations at congresses. Dr Clements has also undertaken crustacean research and established telemetry arrays and associated software. Some of his research techniques and skills involve steroid radio-immunoassay, plasma lactate and glucose and ion determination, histology, and mRNA/DNA extraction and purification. Dr Clements began editing for Edanz Editing in 2007 in areas associated with the biological sciences, especially the fisheries fields.

Professor Emeritus in Chemistry and former Professor of Physical Chemistry, School of Chemistry, University of the Witwatersrand, Johannesburg, South Africa, Professor Scurrell is actively involved in research into heterogeneous catalysis, surface chemistry and materials chemistry, with emphasis on applications in energy conversion processes, environmental catalysis and options for the conversion of coal, natural gas and solar (via biomass) into liquid hydrocarbon fuels. He has a strong interest in nanometal-polymer composites, their synthesis and properties. Professor Scurrell has held various positions over the past 40 years in industry, academia and research institutes in the UK, the USA, Denmark, Italy and South Africa, and presently has consulting interests in South Africa, China and the Middle East. Professor Scurrell has over 150 publications and joined the Edanz Group as an editor in 2011.

Dr Donkin's PhD thesis was entitled "The Effects of the Neuropeptide Substance P on Outcome Following Traumatic Brain Injury in Rats". His research interests include developing novel pharmacotherapeutic agents for the treatment of neurotrauma and neurodegeneration using rodent animal models. He has completed a post-doctoral fellowship at the University of British Columbia, Canada, investigating potential prophylactic and therapeutic compounds in the prevention and treatment of Alzheimer's disease. Dr Donkin has published several peer-reviewed journal articles and currently works as a scientific writer. Dr Donkin joined the Edanz Group as a science editor, writer and reviewer in 2011.

Dr Lodge is a cell biologist with wide-ranging experience in academic research, early stage drug discovery, and stem cell therapy regulatory affairs. For his PhD and postdoctoral work, Dr Lodge studied the roles of the actin cytoskeleton and cell adhesion molecules in axon guidance during nervous system development. Dr Lodge joined GlaxoSmithKline in 2001, where he held research and programme leadership roles within target validation initiatives for neurodegenerative and psychiatric diseases. He was also involved in developing drug discovery strategies involving stem cells. From 2009 to 2011, Dr Lodge was Programme Manager for a stem cell therapy unit at University College London, where he was responsible for the unit obtaining the necessary licenses required by the recently introduced Advanced Therapy Medicinal Products (ATMPs) directive. His technical expertise covers a broad spectrum of cell biology, molecular biology and protein biochemistry techniques, including their application to drug discovery assay development. Dr Lodge has published several first author publications in international peer-reviewed journals, and he is experienced in writing a variety of pre-clinical and clinical regulatory documents. Dr Lodge currently offers consulting services in cell-based drug discovery, ATMP regulatory affairs, and scientific writing (including web development). He began editing for the Edanz Group in 2008.

Dr Jefferies has extensive research experience in molecular parasitology with a particular interest in emerging infectious diseases. He is currently working as a research scientist at the University of Bristol, UK, in the Schools of Biological Sciences and Veterinary Science. Dr Jefferies has published more than 20 research papers and is a reviewer for multiple journals in the fields of parasitology and veterinary science. With experience in both academic and commercial research environments, Dr Jefferies has expertise in the development of novel diagnostic methods, molecular epidemiology, population genetics, phylogenetics, molecular taxonomy and protein characterization. He has also worked on peptide-based drug discovery using yeast two-hybrid systems. Dr Jefferies began working with the Edanz Group as an editor in 2010.

Dr Davies is a biologist with particular expertise in the areas of neuroscience, oncology, and chromatin structure and gene expression. Dr Davies has held Postdoctoral Fellow positions at a number of institutes including the François Magendie Institute for Neuroscience, Bordeaux, France, and the Children’s Cancer Institute Australia. During his PhD, he examined chromatin structure and cisplatin damage at the human beta-globin gene cluster. Dr Davies has been a regular reviewer for several international journals and has edited numerous manuscripts written by both native and non-native English speakers. He has a number of first-author publications in journals such as Nucleic Acids Research and The Journal of Pharmacology and Experimental Therapeutics. Dr Davies has experience in a wide variety of laboratory techniques, including acute and organotypic culture, adenovirus manipulation, lentivirus manipulation and transduction of brain slices and cultured neuronal cells, fluorescent and confocal microscopy, cell microinjection, in vivo mouse models, western blot, electrophoretic gel mobility shift assay, PCR (most varieties), cloning and bacterial plasmid production. Dr Davies began working as an editor for Edanz Editing in 2006.

Dr Kerr originally studied microbiology at Glasgow University and went on to complete a PhD on herpes viruses at Aberdeen University. He then specialized in electron microscopy and continued for a few years in post-doctoral research on ultrasound treatment of cancer. This was followed by a diploma in information studies, and he has worked in medical and drug information since 1991. Dr Kerr has worked previously as an indexer for EMBase and other pharmaceutical databases, a news writer for several journals including Lancet Infections Diseases and Lancet Oncology, and as a copyeditor for Springer and the Society for General Microbiology. In addition to editing, he works on product literature databases for a number of leading pharmaceutical companies. Dr Kerr joined the Edanz Group in 2005 and edits in the medical and life sciences, with a particular interest in microbiology and infectious diseases. He is a member of the Society for General Microbiology.

Dr Kuhn has extensive experience as a research scientist and is well published as a first author. She began as an editor for Edanz Editing in 2007 and edits in fields associated with neuroscience, physiology, brain rehabilitation/repair, postnatal and adult neurogenesis, memory, learning, neurodegenerative disease, stem cells, molecular biology, including PCR, cloning, subcloning, subtractive hybridization, plasmid preparation/purification, cDNA, RNA, and genomic DNA purification. She also has working experience with all associated laboratory tests and skills necessary for that environment.

Dr Mosi’s PhD studies involved the mechanism of reaction of two alpha glycosyltransferases, glycogen phosphorylase and cyclodextrin glycosyltransferase, through the use of modified substrates and inhibitors. Dr Mosi is a senior research scientist with eight years’ experience in pharmaceutical drug research. She has developed and implemented novel assays for the purpose of the identification of inhibitors of metallo-enzymes as antibacterials and inhibitors of cysteine proteases for the treatment of cancer. Dr Mosi has applied expertise in enzymology, receptor based cell biology, drug metabolism and protein purification and production. As well, she has designed and standardized systems and procedures for interpreting scientific results. She also has a sound knowledge of FDA guidelines and is trained in GLP and GMP procedures. Dr Mosi is a past member of the Drug Information Association, International Society for the Study of Xenobiotics, Society for Biomolecular Screening, American Society of Microbiology, and the Canadian Society of Chemistry. As first author of 10 published, peer reviewed manuscripts, and as editor of numerous other papers in fields of biology, biochemistry, chemistry and pharmacology, Dr Mosi brings an extensive writing background to her editing work for Edanz Editing.

Dr Patel is a neuroscientist interested in central nervous system degeneration and mental illness. For his doctoral thesis he developed a mouse gene-knockout model for the human neurological disorder aceruloplasminemia. Subsequently, as a research fellow at the Department of Cell Biology at Harvard Medical School he studied the molecular signaling cascades involved in nerve cell migration. Dr Patel has recently focused his research on the molecular genetics of psychiatric illness as an associate at the Douglas Mental Health Institute in Montreal. His studies center on microRNA signaling networks involved in major depression and suicide. Dr Patel has published a number of first-author articles in high-impact journals, including The Journal of Biological Chemistry and The Journal of Neuroscience. He began editing for the Edanz Group in 2011.

Dr Diwakarla’s PhD thesis involved the use of primary cerebellar granule cell cultures to monitor changes in mitochondrial function and cellular homeostasis after apoptotic injury (excitotoxicity, oxidative stress and trophic factor withdrawal). Her project examined the cellular responses of neurons to a range of insults focusing largely on the activation/recruitment of apoptotic proteins involved both upstream and downstream of the apoptotic pathway. Currently, Dr Diwakarla, who was born in Australia, is a post-doctoral scientist in the Neuropeptides Laboratory at the Florey Neuroscience Institutes were she is monitoring neurogenesis during fetal development and determining the signaling pathways involved in memory formation. She is also contributing to the investigation of neuroprotection in in vitro and in vivo models of ischemic damage. She began working as an editor with the Edanz Group in 2009.

Ms Brunker has been editing biomedical documents for over two decades, including submissions to peer-reviewed journals; dissertations and other academic papers; applications to US regulatory agencies (the Food and Drug Administration and the Patent and Trademark Office); pharmaceutical advertisements of all types; Web site content; slide presentations, scripts and other support pieces for conferences and similar events; and a wide variety of medical education materials. Her master’s thesis was on apoptosis in HIV+ CD4+ cells. She has also done laboratory work in breast cancer and environmental medicine.

Dr Yajima's background is in proteomics, molecular biology, and plant pathology. He is the first author of numerous manuscripts published in peer-reviewed scientific journals. Additionally, he is a co-author of a book chapter, an online encyclopedia chapter, an online technical guide/magazine, and an extensive review article. Prior to joining Edanz, he gained experience in editing/proofreading through freelance work. He has also served as a reviewer for international scientific journals. Dr Yajima joined the Edanz Group as a Senior Editor in the Fukuoka office in November 2011.

Dr Sharman's PhD, in the lab of Peter Holland, focused on homeobox gene duplication in early vertebrate evolution. Her post-doctoral work was with Michael Brand on zebrafish neural development; during which she published three first-author papers and three reviews. Dr Sharman then moved into journal editing. She was Editor of Trends in Biochemical Sciences, Assistant Editor of Current Biology and then Senior Editor of Genome Biology. With seven years experience as an in-house journal editor Dr Sharman understands journal publishing and what peer reviewers require in a manuscript. Dr Sharman attained Advanced Member status of the Society for Editors and Proofreaders in 2010 and edits in all areas of biology and medicine; particularly manuscripts on evolution, developmental biology and genomics. Dr Sharman began editing for the Edanz Group in 2011.

Dr March is a cancer biologist with special interests in cell signaling and intestinal oncology. Her PhD research examined the regulation of AP-1 proteins by MAP kinase pathways. Dr March is currently a Senior Postdoctoral Research Fellow at the Cancer Research UK Cambridge Research Institute, where her work focuses on the application of innovative models to identify and characterize novel driver genes in colorectal cancer. Previously, Dr March was a Postdoctoral Research Scientist at the Babraham Institute, UK, where, in collaboration with UCB Pharma, she studied the mode of action of an anti-epilepsy drug. She also has experience working in the biotechnology industry. Dr March has given invited lectures both nationally and internationally, and has published in several international peer-reviewed journals. Dr March joined Edanz as an editor in early 2011.

Dr Cheesman has a special interest in tropical disease research and has worked primarily in the fields of molecular biology and genetics. For her PhD she investigated DNA topoisomerase II of the human malaria parasite Plasmodium falciparum as an anti-malarial drug target. The research involved studying the expression profile and activity of the enzyme throughout the life cycle of the parasite to determine whether anti-topoisomerase drugs could inhibit it. More recently, Dr Cheesman has been applying genetics and genomics approaches to identify parasite genes of biomedical importance, including genes that induce protective immunity in the host. Her research identified a major parasite gene involved in strain-specific immunity against malaria, an important breakthrough in vaccine research. Dr Cheesman is very interested in the evolution of host-pathogen interactions. She has published 25 original research papers, many as first author and has been an invited speaker at many congresses. Dr Cheesman has also taken research sabbaticals at the University of Osaka (2007) and University of Nagasaki, Japan (2009). She joined the Edanz Group as an editor in 2010.

Dr Rogers presently is a lecturer in scientific communication and writing at the University of Geneva, Switzerland. He has previously held research positions as a laboratory head within the biotechnology industry, specializing in proteomics research, and within the food industry, conducting research in primary materials. He completed post-doctoral research within the University of Paris, as a Royal Society Fellow, and at the University of Sussex. He has published widely and is joint author to seven biotechnology patents. Dr Rogers began working as an editor for the Edanz Group in 2010.

Dr Burkala is currently employed at the University of Oklahoma in the Department of Microbiology and Immunology. Dr Burkala has many years of experience in molecular virology and biology, and has recently specialized in HIV immunology and evolution. He has peer-reviewed publications in a broad range of scientific areas including cancer biology and immunology in addition to reviewing many publications and grant applications. Dr Burkala’s technical skills include: cutting-edge molecular biological techniques such as heteroduplex tracking assays and mass spectrometry; common techniques like cloning, PCR, real-time PCR and recombinant protein purification; immunological techniques such as flow cytometry, ELISA, Western immunoblot and ELISPOT; cell culture techniques including primary and cell line culture, virus culture and purification, transwell migration assays and confocal microscopy; and live animal experiments including the use of mice, sheep, cattle, and rabbits for immunizations and immunological analyses.

Dr McAlpine's PhD research focused on the effects of inflammation, specifically Tumor Necrosis Factor, on the progression of neurodegenerative diseases. This research focused mainly on Alzheimer's disease, with some work on Parkinson's disease. She made extensive use of rodent models of these diseases, and administered both drugs and gene therapy vectors to the brains of affected animals. She has published both primary research articles and reviews on this topic. After her PhD, Dr McAlpine completed a postdoctoral fellowship studying autophagy in the UK. Dr McAlpine joined the Edanz Group as an editor in 2011.

Dr Biswas is a bioinformatics scientist with experience in DNA/protein database annotation, sequence analysis and molecular modeling. For seven years Dr Biswas was a Post-Doctoral Research Associate using molecular modeling techniques to study protein-ligand binding. She then joined the newly formed Bioinformatics Centre at the Indian Institute of Science as a Senior Scientific Officer responsible for the development of training courses and research projects. Dr Biswas returned to the UK in 1998 as a Database Curator at the European Bioinformatics Institute, Cambridge, where she was involved in database production, annotation and research. From 2002 to 2009, Dr Biswas worked as a Bioinformatics Scientist for a private company in New Zealand. She worked in a range of projects aimed at understanding how genes and other factors interact to influence complex biological traits in animals and plants. Dr Biswas, a Scottish-born native speaker of English, has extensive writing and publication experience. She has published 24 papers in international peer-reviewed journals and has co-authored scientific book chapters. Dr Biswas began editing for the Edanz Group in 2010.

Cameron McLeod is Emeritus Professor (Chemistry) at the University Of Sheffield, having been Director of the Centre for Analytical Sciences (1995–2011) and Head of Department of Earth Sciences (1997–2000). His research focus has been in trace element spectrochemistry, and laser and plasma spectrochemical analysis, Professor McLeod has published extensively in these areas, and in the fields of atomic mass spectrometry and laser ablation. His work has had an impact on the environmental, materials and life sciences sectors. Professor McLeod has served on the boards of several leading Analytical Science journals. He joined the Edanz Group as an editor and specialist reviewer in 2011.

Dr Finnie is a stem cell biologist whose PhD research led to the identification and isolation of rare stem cell populations within umbilical cord blood, with the potential for bone and cartilage tissue engineering applications. Dr Finnie was then a senior Postdoctoral Research Scientist at Smith & Nephew's research center in the UK, where she worked at the forefront of both research and development stages to commercialize adult stem cell therapies for regenerative medicine, namely bone replacement and Osteoarthritis. Dr Finnie has published her research in international peer-reviewed journals. She is currently a science writer and editor across diverse biological areas and is a member of the European Medical Writers Association (EMWA). Dr Finnie joined Edanz as an editor in November 2011.

Dr Roth has published articles on T cell biology, the molecular mechanisms of gene rearrangement, hematopoeisis, developmental biology, neurobiology, and nuclear receptor biology. He has extensive experience with transgeneic animal models, developing genomic and proteomic based technologies, and applying gene and protein expression profiling methods to diseases and therapeutic areas, including diabetes, obesity, blood disorders, and oncology. He is a co-author on 13 publications in high impact journals, and the co-inventor on five issued patents. He has consulted with leading biopharmaceutical, medical device, and life science companies on new platform technologies and product development. As an adjunct professor at Quinnipiac University, he taught an undergraduate online biology course for several years. He received an American Cancer Society Postdoctoral Fellowship while at Northwestern University, and studied developmental neurobiology at Cold Spring Harbor, New York. Dr Roth began working with Edanz Editing as an editor in 2010.

Dr Murphy researches at the interface of chemistry and biology, focusing on natural products involving small, but complex, molecules produced by organisms to gain an evolutionary advantage over their competitors. Her PhD investigated the total synthesis of natural products and the use of organic synthesis as a tool in natural product structure elucidation. She then joined the Simpson group at the University of Bristol, UK, working on a multidisciplinary project aiming to understand more about the biosynthesis of natural product antibiotics, and the complex enzymes that produce them from simple primary metabolite building blocks. She has significant experience in the areas of organic synthesis, analytical and biological chemistry. Dr Murphy began working as an editor with the Edanz Group in 2010.

Dr Bijur's work is on neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and investigations into brain metabolic functions. Dr Bijur has extensive experience in the areas of psychiatry, including schizophrenia and bipolar disorder, metabolic disorders such as diabetes, and in oncogenesis and carcinogenesis. He has thorough understandings of cell culture techniques, molecular biology techniques, and rodent animal models. His personal research has been funded by the U.S. National Institutes of Health and the National Alliance for Research on Schizophrenia and Depression. Dr Bijur has authored over 32 peer-reviewed publications, and has presented at numerous scientific conferences including the Society for Neuroscience and the American Association for Cancer Research, among others. He also serves as a reviewer for several biomedical journals and granting agencies. Dr Bijur joined the Edanz Group as an editor and medical writer in 2010.

Dr Devenish's current research examines the role of quaternary structure in enzyme function. His PhD was obtained in organic chemistry, in the field of natural products isolation and hemisynthesis, and also involved significant amounts of peptide synthesis as well as polymer chemistry. Dr Devenish’s recent research has been in the field of enzymology, where he has worked on biochemical and biophysical characterization of enzymes, molecular cloning techniques and site-directed mutagenesis. Dr Devenish continues in active research, and has a successful publication record. Dr Devenish started working with the Edanz Group in 2009.

Dr Dean’s PhD thesis was titled “Endogenous Neural Excitation and Inhibition and the Evolution of Preterm Brain Injury.” Dr Dean is presently a post-doctoral research fellow in fields related to neuroscience. He has experience in large animal and fetal surgery techniques, including catheter and electrode placement and animal post-mortem and dissections, as well as in stereotaxic placement of microdialysis and laser Doppler probes. In electrophysiology, Dr Dean is skilled in the instrumentation, recording, and analysis of electrophysiological data in vivo, including cortical EEG spike wave and seizure activity, cerebral impedance, cerebral near-infrared spectroscopy (NIRS), cerebral laser Doppler, temperature, ECG, EMG, blood pressure, ultrasonic blood flow measurement, and fetal breathing movements. He possesses training in systems physiology, as well as an understanding of the complex and unique cardiovascular and central nervous system responses. In molecular fields, Dr Dean covers the various blot analysis techniques, primer design and sequence analysis, mRNA and protein extractions, RT-PCR and gel electrophoresis. Histology including staining and analysis of brain tissue and imaging and the associated laboratory skills are all areas in which Dr Dean has experience. Dr Dean began as an editor for Edanz Editing in 2007, and works in fields related to chemistry and neuroscience.

Ms Weidow is a freelance scientific and medical editor with over 6 years experience as a writer and editor in academia, healthcare, and industry. Ms Weidow has degrees in microbiology, statistics, and English from The University of Tennessee, with additional training in scientific writing at Vanderbilt University. She did her thesis research in a multidisciplinary cancer biology laboratory, where she designed small peptide therapeutics for the adjuvant treatment of some cancers. She has worked in academic laboratories for many years, and has contributed in various capacities (writing, editing, data analysis) to hundreds of peer-reviewed journal articles, book chapters, funded grant proposals, patents, abstracts, posters, standard operating procedures, media releases, and many other types of technical literature. Ms Weidow is a member of the Council of Science Editors, the American Medical Writers Association, and the Society for Scholarly Publishing. She edits and writes in a wide range of subject areas – most notably microbiology, cancer biology, oncology, cell biology, matrix biology, bioengineering, immunology, biostatistics, and method development. She began working as an editor with the Edanz Group in 2010.

Dr Williams’ PhD investigated the role of non-viral delivery in gene therapy. She then spent three years working as a postdoctoral researcher on the gene regulation of cystic fibrosis. Dr Williams’ main areas of expertise are genetics, cell biology, molecular biology, biochemistry, plant sciences, medicine, surgery, microbiology and biotechnology. Dr Williams has published several first-author articles in peer-ranking journals and presented her work at international conferences. She has also been a finalist in the (UK) Young Science Writer of the Year award with a report on the role of a speech and language gene in the evolution of humans. Dr Williams joined the Edanz Group as an editor in 2012.

Dr Benyon is a researcher for the USDA-ARS in the US Horticultural Research Laboratory, which concentrates on improving citrus and specialty crops. His current research involves identifying genetic targets for combating Huanglongbing/Citrus greening in citrus, the bacterial pathogen, and the insect vectors. Dr Benyon has a diversified science background, including having researched antimicrobial peptides at the Howard Hughes Medical Institute. Dr Benyon has also worked in East Asia with scientists from Fujian Agriculture and Forestry University, China, and was a post-doctoral associate at Okayama University in Japan. Dr Benyon began editing for the Edanz Group in 2011.

Following the completion of her PhD in biochemistry, Dr Bell was a post-doctoral fellow in the department of Medical Biochemistry at Gothenburg University, Sweden, and then in the department of Behavioural Neuroscience at OHSU, USA. Her postgraduate research focused on the isolation, regulation, action and biological effects of constitutively active MAPK molecules in a eukaryotic yeast model with reference to mammalian MAPKs. Her first post-doctoral post investigated the regulation of the transcription factor FoxC2 and the role of the PKA regulatory subunit RIIβ in adipocyte metabolism. This research had direct relevance to obesity and Type II diabetes. Following this research she then moved into the field of biochemical neuroscience, studying the signaling pathway of the D2 dopamine receptor in relation to receptor tyrosine kinases (RTKs) and MAPK in primary neuronal cultures and in vivo. Throughout her career Dr Bell gained experience with a wide range of molecular biology techniques including genetic manipulation, yeast and mammalian cell culturing, animal breeding and dissection, DNA and mRNA analysis, molecular staining, imaging and protein biochemistry. Dr Bell has published 6 peer-reviewed papers, 3 as first author. Dr Bell also holds a patent related to her development of constitutively active MAPKs. Her current interests include the fields of scientific communication and education. Dr Bell joined the Edanz Group as an editor in 2010.

Dr de Boo is a physiologist with a particular interest in fetal growth and metabolism. Her PhD thesis was entitled “Aspects of Nitrogen Metabolism in Intrauterine Growth Restriction,” focusing primarily on urea cycle disorders in growth-restricted human neonates and fetal sheep. She has since completed a post-doctoral study on the development of intrauterine treatments for intrauterine growth restriction by hormonal supplementation. Dr de Boo has extensive experience in writing and editing both scientific and non-scientific manuscripts and is now a full-time freelance editor.

Dr Brotchie is actively researching the modification and functionalization of metal surfaces. His PhD was in the field of acoustics and sonochemistry. Dr Brotchie is the author of 10 high-impact peer review journal publications and two book chapters, and has given numerous presentations at international conferences. He joined the Edanz Group as an editor in 2011.

For his PhD, Dr Wilhelmi researched the bioremediation of heavy metals from contaminated mine waste waters. He then worked in a doping control Research and Development laboratory investigating immunological techniques for the detection of corticosteroids. On returning to academia his research has been in a number of biochemical fields, including P450 drug metabolism, DNA barcoding, continuous fermentation and bioremediation. His current research involves the isolation of liver microsomes, cloning, expression and characterization of P450 isoforms. This research is aimed at determining the metabolism of various novel compounds and drugs of abuse. A second research interest investigates the potential of using DNA markers for determining the diet of elusive and dangerous herbivores on South African game reserves. In particular the work has investigated the rbcL gene as a biomarker for plants consumed by these herbivores. Dr Wilhelmi is a senior lecturer at Rhodes University, where he teaches metabolism, analytical techniques and forensic biochemistry. He has presented at conferences and has published in the areas of chromatography and analytical biochemistry, conservation biochemistry, and enzymology. Dr Wilhelmi joined the Edanz Group as an editor in 2012.

Prof Takemoto is a University Distinguished Professor Emeritus at Kansas State University, Manhattan, KS, USA. He has extensive experience in the cell biology and protein chemistry of the eye, which he has studied for over 30 years. His research has been continuously funded by the National Institutes of Health of the US. He has served on numerous national and international boards dealing with vision research, including the Board of Scientific Counselors of the National Eye Institute, Lens & Cataract Panel of the National Eye Institute, and the Board of Directors of the Association for Research in Vision & Ophthalmology (ARVO). Prof Takemoto, though US-born, traces his ancestry back to Japan and has conducted research and traveled extensively in Japan as a Fellow of the Japan Society for the Promotion of Science. He has published over 150 peer-reviewed manuscripts, and joined the Edanz Group as an editor in 2011

Dr Zagami's scientific research has focused on the study of the normal development and function of the nervous system and the aberrant processes underlying neurological diseases. Her early studies involved the development of an organotypic spinal cord slice culture model of the motor neuron disease amyotrophic lateral sclerosis (ALS). Dr Zagami's PhD studies examined the roles of excitotoxicity and oxidative stress, two processes implicated in ALS, on glutamate transporter function and cell death. Particular attention was focused on astrocytes and their role in regulating glutamate transporters, as well the effect of these mechanisms on motor neurons. Dr Zagami’s postdoctoral work at the Montreal Neurological Institute, McGill University, Canada, aimed to gain a better understanding of the development of certain brainstem neuronal populations by focusing on a protein with an important role in neuronal subtype specification and axon targeting in other areas of the nervous system. Dr Zagami joined the Edanz Group as an editor in 2011.

Prof Mackraj is an Associate Professor in the Discipline of Human Physiology, School of Laboratory Medicine and Medical Sciences, University of Kwazulu-Natal. She teaches Human Physiology and Human Genetics at the Faculty of Health Sciences and the Nelson R Mandela School of Medicine. She is responsible for running a gene expression laboratory. Her main research focuses are hypertension and its management using medicinal plants; and the etiology and treatment of pre-eclampsia. Prof Mackraj’s postdoctoral work involved the generation and characterization of a gene-disrupted proximal tubular cell model for the investigation of transporter mechanisms in the kidney. Her current research projects involve the investigation of blood pressure lowering plants with a focus on the renin-angiotensin system; and the etiopathology of pre-eclampsia in the local population. She is also a participant in projects involving novel drug delivery systems. She is a well-published author in ISI-listed journals, and is the Principle grant-holder for her research projects. Prof Mackraj joined the Edanz Group as an editor and reviewer in 2011

Dr Barnett's PhD thesis, "Effect of variation in maternal protein intake during gestation and lactation on fuel metabolism in the offspring - studies in the rat", investigated the effects of early nutrition on pancreatic function and insulin metabolism. Dr Barnett post-doctoral studies investigated the role of omega-3 and omega-6 fatty acids on intestinal inflammation in a mouse model using 'omics' technologies such as microarrays and proteomics. He is currently a Senior Research Scientist working for AgResearch in New Zealand; recently working in the field of epigenetics, in particular DNA methylation. Dr Barnett has published 20 peer-reviewed journal articles (11 since 2010) and one peer-reviewed book chapter, and has been an invited speaker at a number of international conferences. Dr Barnett joined the Edanz Group as an editor in 2011 with editing expertise in physiology, genomics/proteomics/metabolomics, epigenetics and intestinal inflammation and immunity.

Carlotta Shearson did two years of undergraduate research on the synthesis of small molecules for neurotoxicity studies. Her graduate work was in the laboratories of Professor Clayton Heathcock at the University of California at Berkeley, where she worked on the synthesis of a potential HMG-CoA reductase inhibitor. She then spent four years working as a synthetic organic chemist in the agricultural chemicals industry, synthesizing novel pesticide candidates. She has been a freelance editor of books and scientific journal articles since 1991, working on a wide range of topics spanning chemistry, biochemistry, and molecular biology. For the past 15 years, she has specialized in editing scientific journal articles by authors for whom English is a second language. Ms Shearson joined the Edanz Group as an editor in 2011.

Dr Tinsley completed his PhD at the School of Medicine at Flinders University of South Australia. His thesis title was "Non-Viral Glial Cell Transfection: A Therapeutic Strategy for CNS Regeneration." His post-doctoral training was in the neural stem cell laboratory of Prof Peter Eriksson, the first to demonstrate neurogenesis in the adult human brain. Dr Tinsley returned to Australia to work at the Howard Florey Institute, investigating models and diagnosis of Parkinson's disease. He has over ten years experience in medical research, and has published widely in leading journals in his field, including Annals of Neurology. Dr Tinsley began working as an editor with the Edanz Group in 2011

Dr Fayle’s PhD focused on Food Chemistry. Her postdoctoral research was done in the Department of Food and Nutrition at the University of Reading, UK. She then worked as a scientist for Crop and Food Research in New Zealand. Dr Fayle’s laboratory skills include both traditional gel electrophoresis and capillary electrophoresis techniques, HPLC, organic synthesis, protein purification and identification, and NMR. Dr Fayle has expert knowledge of the Maillard Reaction, and is the author of a Royal Society of Chemistry monograph on this reaction. She also has authored twenty related publications, and has been an invited speaker at international conferences in her field of study. She began working with the Edanz Group as an editor in 2010.

Dr Alan Robinson is a senior process chemist working in the agricultural industry. His work requires a deep understanding across a wide range of chemical fields. He has extensive experience in organic and physical organic chemistry, especially with respect to synthesis, mechanism and kinetics. Dr Robinson completed his PhD, based on the development and understanding of new catalysts for diene and enyne metathesis, with internationally acclaimed Prof Lloyd-Jones in 2005. He has spoken and presented prize winning posters at numerous symposia, and recently co-authored an important paper in Chemistry – A European Journal. Dr Robinson began working with the Edanz Group as an editor in 2010.

Currently, Dr Werry is at Queen Mary University of London studying dentistry. Prior to this, he worked for GlaxoSmithKline Ltd in the Neurosciences Centre of Excellence in Drug Discovery in Harlow, UK. Dr Werry studied G protein-coupled receptor (GPCR) pharmacology and cellular signaling as part of his PhD in a thesis entitled "The effects of crosstalk on GPCR-mediated calcium signaling pathways". He has also worked in one of the premier pharmacology labs in the world with Prof Arthur Christopoulos at Monash University, Melbourne, Australia, studying cellular signaling by variants of the serotonin 5HT2C receptor and the pharmacology and cell biology of mitogen-activated protein kinase signaling. Dr Werry's work has produced numerous publications including original research papers and authoritative reviews on calcium and ERK signaling and 5HT2C receptor RNA editing. His areas of expertise include pharmacology, neuroscience, G protein-coupled receptors, and cellular signaling. Dr Werry began working with the Edanz Group as a writer and editor in 2010.

Dr Byrne’s PhD studies in neuroanatomy and neuropharmacology have centered on the role of oxidative stress in neurodegenerative diseases. In her research she investigated the expression and activity of the pro-oxidant enzyme, myeloperoxidase, in post-mortem human brain tissue and in cellular models of neurofibrillary pathology. She has published two papers in international peer-reviewed journals and is currently a teaching fellow in human biology at the University of Otago, New Zealand. She began working as an editor for the Edanz Group in 2010.

Dr Dawes’ PhD focused on neuroprotective drugs and their effects on retinal ischemia. Before undertaking her PhD, Dr Dawes spent 15 years as a senior research assistant at the National Institute for Medical Research, London, studying neuronal plasticity in the amphibian visual system. Dr Dawes’ then began research at St Bartholomew’s Hospital Medical School, London, studying the effects of dietary antioxidants on lipid peroxide formation in animal tissue after whole body irradiation. She has been an author on 15 peer reviewed papers and has given presentations at national and international scientific meetings. Dr Dawes’ experience has covered techniques in radiation biology, biochemistry, anatomy, histology, neurophysiology and neuropharmacology. Concurrent with her research, for 38 years Dr Dawes has been an assistant lecturer at the Open University, UK, teaching neurobiology, psychology and foundation sciences. Dr Dawes now works between the UK and China, and began working as an editor with the Edanz Group in 2010.

Ms Malapetsas is a medical and scientific editor/writer with experience in the development of content in the various areas in the life sciences for both medical research institutes and pharmaceutical advertising agencies. Initially a research assistant in a cancer research laboratory at the Lady Davis Institute for Medical Research in Montreal, Canada, she performed molecular and cellular biology experiments—including mRNA, DNA, and protein extraction and purification, Northern and Western blots, RT-PCR, cellular transport, primary tissue culture, and various drug efficacy studies. She also developed laboratory documents for submission to journals and funding agencies. Ms Malapetsas then worked in pharmaceutical advertising, where for eight years she undertook proofreading, copyediting, and fact-checking, and wrote medical education programs delivering on-label drug information to physicians and healthcare professionals. Ms Malapetsas also has extensive experience as a freelance medical and scientific editor/writer for research laboratories and corporate entities. Ms Malapetsas began working as an editor with the Edanz Group in 2009.

Dr Jackson’s PhD investigated bone healing mechanisms, focusing on mechanical loading and growth factors as healing agents, as well as fracture repair strategies. Her earlier studies had a strong focus toward human anatomy, physiology and forensic osteology. For five years Dr Jackson was a post-doctoral research fellow at the Institute of Molecular and Cell Biology in Singapore, where she also acted as an in-house scientific editor. Her postdoctoral research explored protein-protein interactions within signal transduction cascades, and the role of particular tumor-suppressor genes in breast cancer and mammary gland development. Dr Jackson has published 13 papers in peer-reviewed journals and has 16 conference papers. Dr Jackson also has a certificate in Professional Editing and Proofreading, and began editing for the Edanz Group in 2010.

Dr Stevenson is a chemist who has served as principal investigator on a variety of projects in areas of organic and polymer chemistry. His PhD research on hypervalent organosilicon compounds involved both synthetic and mechanistic work as well as extensive use of spectroscopy. After graduation he was employed at Owens-Corning Fiberglas from 1984–1986, synthesizing organosilicon compounds for use as coupling agents in fiberglass reinforced composites. He then worked on projects dealing with the synthesis, formulation, and testing of energetic compounds in propellants and explosives. A former chairman of the North Alabama Section of the American Chemical Society, he has published a number of articles in prestigious journals such as the Journal of the American Chemical Society and the Journal of Organic Chemistry. Dr Stevenson began work as an editor for the Edanz Group in 2010.

Dr Vocadlo is a chemist with six years’ experience in medicinal chemistry and drug product development in biotech companies. As a researcher she was involved in multi-step synthesis and spectroscopic analysis of compounds, including experiment planning, execution, compound isolation, purification and identification. Dr Vocadlo has also gathered and evaluated information, and then prepared regulatory submissions for NDA (New Drug Applications of the US FDA). As well as being a published first author, Dr Vocadlo has extensive experience in technical writing and editing (theses, manuscripts, protocols and reports). Dr Vocadlo began working with Edanz Editing in 2007.

Dr Takemoto is a Professor Emeritus of Biochemistry at Kansas State University, where she has taught and conducted research for 32 years. Her research on the role of ischemia in lens and retinal diseases is funded through the National Eye Institute of the National Institutes of Health. Areas of expertise include biochemistry, molecular biology, protein chemistry, cell signaling, metabolism, eye and neural disorders, pharmacology, biology and enzymology. Dr Takemoto has reviewed for numerous journals, including the Journal of Biological Chemistry, Current Eye Research, Investigative Ophthalmology and Visual Sciences, and Biochemistry. She also served, for eight years, on the Small Business: Visual Systems Study Section for the National Institutes of Health, where she reviewed both SBIR and STTR grant proposals. Dr. Takemoto has published over 100 peer-reviewed works, including book chapters, original works and a textbook and lab manual for non-science majors. She joined the Edanz Group as an editor in 2011.

Dr James’ PhD thesis, and initial postdoctoral work, was on the characterization of DISC1, a susceptibility gene for psychiatric illness. Subsequent postdoctoral research focused on acute brain injury and the mitochondrial response in a transgenic mouse model. Dr James understands brain biology with a particular interest in psychiatric illness, neurodegenerative disease, genetics and cellular biology. She has multi-disciplinary laboratory expertise in a number of techniques, covering protein biochemistry, cellular and molecular biology, histology and microscopy. Dr James has experience of human tissue studies, as well as transgenic animal models and cell culture systems, including embryonic stem cells. From her research she has co-authored several peer-reviewed papers, including a Science paper, which was cited as one of the top ten breakthroughs of 2005. Dr James joined the Edanz Group as an editor in 2011.

Dr Sheen is a postdoctoral research fellow at San Diego State University, studying microbial pathogenesis. Her work encompasses microbial niche establishment as well as penetration of the blood-brain barrier. She also has two patents for the development of novel therapeutic agents for treatment of MRSA infections. Dr Sheen carried out her PhD research at AgResearch in Lincoln, New Zealand, focusing on applying genetic techniques to improve the soil survival of a microbial biocontrol agent. Her other research has involved the phylogenetic analysis of Antarctic notothenioid fish and species evolution. Dr Sheen began editing for Edanz Editing in 2011.

Ms Igelstrom currently works as an electrophysiologist at the University of Otago. She has a background in biochemistry and physiology, and is now specializing in neuroscience. Her PhD research focused on brain slice models of epileptic seizures, and she is currently investigating ion channel modulators for antiepileptic drug treatment. She has experience with a variety of electrophysiological techniques, including whole-cell voltage/current clamp, cell-attached tight-seal current clamp, field potential recording, and single-unit recording. Her past and current research interests include behavioral reward conditioning, olfactory processing, non-synaptic neurotransmission, epileptic seizures, antiepileptic drugs, and antidepressant drugs. Ms Igelstrom also has a special interest in the physiological effects of alternative and complementary therapies, such as Chinese medicine and yoga. Apart from her electrophysiological skills, Ms Igelstrom also has experience with cell culture, western blotting, microscopy, behavioral rat training, and immunohistochemistry. Ms Igelstrom joined the Edanz Group as an editor in 2011.

Dr Colton's research background in biochemistry focused on lipid biochemical pathways in marine invertebrates and mammalian skin. His doctoral thesis involved describing the biochemical pathways for sebaceous lipid production in the genus Equus through radio-label, structural analysis, and comparative biochemical studies. His post-doctoral work involved relating the giant ring lactones of equine sebum to the epidermal water barrier of mammalian skin. Dr Colton is a generalist scientist and, as a college professor, taught courses from inorganic and organic chemistry to biochemistry and molecular biology to nuclear physics and astronomy. He has advised and edited numerous theses, papers, and articles for colleagues and students. He has published 13 papers in peer-reviewed journals and has been an active editor since 2007. Dr Colton began editing for the Edanz Group in 2009.

Dr Hitchin is a synthetic organic chemist with over eight years of experience in the pharmaceutical and fine chemical industries. He is skilled in the areas of synthetic chemistry, medicinal chemistry and process research and development. Dr Hitchin's PhD investigated the synthesis and application of poly-functionalized quinuclidine systems. He is currently a Senior Scientific Officer for Cancer Research UK at the Paterson Institute of Cancer Research in the UK, where he leads a team of medicinal chemists investigating novel drug discovery targets in oncology. Dr Hitchin has also worked as a Chemistry Group Leader for Pfizer Global Research and Development at the Sandwich laboratories in Kent, UK, where he was responsible for the successful design and implementation of synthetic strategies across therapeutic areas including pain, obesity and virology. Further to this, Dr Hitchin has worked providing c-GMP manufacture in an FDA approved facility. Dr Hitchin has published in several peer-reviewed journals. He joined the Edanz Group as an editor in 2011.

Dr Barber is a cell biologist with experience in small G-protein signaling. His initial research investigated the differing patterns of gene expression in the white blood cells of patients diagnosed with a systemic immune response. Dr Barber’s PhD research from the University of Cambridge described the regulation of Rac-GEF P Rex1 and resulted in two first author publications. More recent studies have focused on cell-signaling pathways. While working in a prominent research institutes in the UK he published a mini-review on Rac-signaling in cancer. Dr Barber has experience with a wide range of biochemical and cell-based assays including recombinant protein techniques and immunofluorescence microscopy. Dr Barber joined the Edanz Group as an editor in 2011.

Dr Anderson’s PhD research focused on the effects of manganese toxicity and iron deficiency on the biology of the neurotransmitters GABA and norepinephrine. He is currently a postdoctoral research fellow at the Center for the Study of Complementary and Alternative Therapies at the University of Virginia. His research interests include the use of dietary and mind-body therapies for the prevention and management of neurodegenerative diseases such as Alzheimer’s disease and dementia. Dr Anderson has experience in basic science in addition to his current clinical research. Before his PhD, he was the laboratory manager of two cancer research labs at the Wake Forest University School of Medicine. Dr Anderson has expertise in various in vitro techniques, including cellular studies, molecular biology (western blotting, RT-PCR and immunocytochemistry), microscopy (brightfield and fluorescence), microbiology, and analytical chemistry, as well as in vivo work with mouse and rat models including stereotaxic surgery and microdialysis. Dr Anderson has over a dozen publications in peer-reviewed journals, as well as book chapters, and has presented at national and international conferences. He joined the Edanz Group as an editor in 2011.

Dr Eve McCutchen Vick's research has included studies of hippocampal synaptic plasticity, degeneration of hippocampal cholinergic innervation, and modulation of neuronal signaling by neurotrophic factors. Her expertise includes learning and memory, synaptic plasticity, hippocampal physiology and intracellular signaling, cholinergic and adrenergic receptors, electrophysiology and immunohistochemistry. Dr Vick is well published in high-ranking journals, and has edited manuscripts across a variety of subject areas, including neuroscience, pharmacology, toxicology, and cardiology. She has also taught undergraduate courses in both Psychology and Anatomy and Physiology at several institutions in the US. Dr Vick joined the Edanz Group as an editor in 2011.

Dr Ao completed her PhD studies in Biochemistry and Molecular Biology, with a focus on cancer biology and anti-estrogen therapy resistance. She is currently a postdoctoral fellow at Vanderbilt University, conducting research in the interdisciplinary field of regenerative chemical biology. She has composed and published a number of peer-reviewed articles, a review article, and a book chapter for a broader scientific audience. The topics ranged from the influence of epigenetics on cancer biology, chemical biology in regenerative medicine, and the role of cancer stem cells in anti-estrogen therapy resistance. Dr Ao joined the Edanz Group as an editor in 2011.

Dr Cleary is a biomedical scientist with a special interest in cancer research and chronic disease. Her doctoral thesis was entitled “From chromaffin cells to phaeochromocytoma: insight into the sympathoadrenal lineage”. Dr Cleary was a Post Doctoral Fellow with the National Institutes of Neurological Disorders and Stroke (NIH), where she was the lead researcher on a project investigating novel strategies for the treatment of metastatic kidney disease. Dr Cleary has an extensive history of research in cancer tumor biology and an interest in the developmental origins of cancer, especially those related to mutations of the von Hippel-Lindau gene. Dr Cleary has an interest in health policy and was a Fellow with the Fogarty International Center at the NIH. During this time she was involved in a number of global health policy projects. Dr Cleary has published a number of articles in peer-reviewed journals in addition to other science writing for a non-technical audience. Dr Cleary began working as an editor for the Edanz Group in 2010.

Dr Price's training is as a pharmacologist, with specific emphasis on molecular pharmacology, signal transduction, and neuroscience. His research includes extensive work on immunophilins, a class of compounds that promote nerve regeneration. He has worked in both pharmaceutical and small biotechnology companies in Japan, the US, and Europe. He has published over 20 research articles, including an invited review. Over the past seven years, Dr Price has edited/co-written over 1100 scientific publications, presentations, and regulatory documents. Dr Price began as an editor with the Edanz Group in 2008.

Mr Gorman has 35 years of experience in the healthcare system in Canada. He has worked as a project manager, research coordinator, department head, consultant, respiratory therapist, and more recently as a medical editor. Mr Gorman is familiar with AMA guidelines and ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals. For the past four years he has worked as a freelance medical editor for medical researchers at the McGill University and University of Montreal Research Centers in Montreal, QC, Canada. Mr Gorman joined the Edanz Group as an editor in 2011.

Dr Cornforth is a Naturopathic Physician with over six years of medical writing and scientific editing experience. Her areas of clinical expertise include herbal medicine, nutrition, endocrinology, and women's health. She has also worked as a health informatics consultant analyzing published research and building risk analysis software. Dr Cornforth is a member of the American Medical Writers Association. Dr Cornforth began working with the Edanz Group as an editor in 2010.

Ms Garcia obtained an MSc in Bio-Systems Sustainability, specializing in Bioorganic Chemistry, from Hokkaido University, Japan, and is currently a PhD candidate in Food Science at the University of Auckland, New Zealand. Her research is focused on flavor and fragrance chemistry, and she has worked on the characterization of the aroma profiles of flowers and fruits. Her work involves the isolation of volatile and non-volatile compounds, the use of instrumentation (GC-MS, NMR, etc.), and the use of enzymes. She has presented her research at conferences in Japan, New Zealand and China. Ms Garcia also has a broad background in the life sciences, including the isolation and characterization of bioactive compounds and enzymes. She is fluent in English, and speaks and reads Japanese and Spanish. She joined the Edanz Group as an editor in 2011.

Ms Davis has worked in research and development in the areas of biochemistry and molecular biology at several academic institutions in the U.S., Germany, and Denmark. For the last 20 years, she has been employed in biotechnology companies in California where she was involved in heterologous gene expression in yeast and diagnostic assay development as well as laboratory operations. During this time, she was also responsible for editing scientific articles and biotech business documents. She joined the Edanz Group in 2010.

After studies in biochemistry and microbiology at the University of Victoria, Ms Bogh worked as a biomedical researcher with biotechnology companies and university departments. For the last 10 years she has worked for publishers of international, peer-reviewed scientific and technical journals and has edited manuscripts in many disciplines including microbiology, chemistry, biochemistry, molecular biology, and genetics. Ms Bogh is a board-certified Editor in the Life Sciences and recently earned a Postgraduate Certificate in Editing from the Department of Linguistics at Macquarie University. She joined the Edanz Group as an editor in 2012

Dr Aprico's doctoral thesis was "[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters." From 2003 to 2005, Dr Aprico held a post-doctoral position at Arvid Carlsson Institute, Göteborg, Sweden, working with Dr Michael Nilsson, investigating in vitro models of reactive astrogliosis. Since 2005, Dr Aprico has been a university lecturer in pharmacology and physiology, but returned to university to obtain her medical degree in mid-2009. Dr Aprico began as an editor with the Edanz Group in 2008.

Mr Arico has been working and studying in the Australian scientific sector for the past several years and has held research positions at internationally recognized organizations such as the Queensland and Garvan Institutes of Medical Research. During this time his research focused on Cancer Immunotherapy and Immunology. Mr Arico has also worked in the private biotechnology sector in the area of Molecular Diagnostics. Mr Arico completed his honors degree in 2006 under the direction of a prominent Professor of Stem Cell Sciences at Monash University researching definitive endoderm differentiation from human embryonic stem cells. His technical skills include: cell culture including human and mouse embryonic stem cells, in vitro cell differentiations using embryonic and adult stem cells, various imaging techniques, cell-based assays, flow cytometry, cell purification techniques, PCR, cloning and retroviral transfections. Mr Arico has a strong interest in tissue engineering technologies and the clinical use of stem cells. He began working as an editor with the Edanz Group in 2011.

Ms O'Connor’s PhD thesis entitled “Consequences of primary cilia ablation in the developing limb and epidermis” will be submitted in early 2012. She is also a graduate of the 2010 Embryology course at the Marine Biological Laboratory in Woods Hole, MA. Ms O’Connor is presently researching in fields related to hedgehog signaling, limb and bone development, and primary cilia. She has experience in mouse breeding, genetics, histology, transgenic and knock-in model generation, development, and embryology. In vitro techniques Ms O'Connor is skilled in are primary cell culture, qRT PCR, western blotting, confocal imaging, and in situ hybridization. She has extensive training in embryology and development, as well as an understanding of the complex signaling pathways involved in pattern formation, cell fate determination, and specification. Ms O'Connor has published a methods chapter on the generation of mouse models, and has 3 peer-reviewed publications. She is a regular attendee and presenter at the American Society for Cell Biology annual meeting. Ms O'Connor began as an editor with the Edanz Group in 2011.

Mr Granville's research has included work on the expression of immediate early genes in the rat hippocampus, and involved extensive use of primer design and sequence analysis, gel electrophoresis, and quantitative PCR. He has also studied Science Communication specializing in non-fiction writing, and has studied the history and philosophy of science over a wide range of disciplines including psychology, neuroscience, pharmacology, biochemistry, and molecular and cell biology, focusing on developments from the late 19th to mid-20th centuries. He joined Edanz Group in 2010 as a science editor and writer.

Ms Bass is a science writer and editor focused on academic medicine and clinical research. Since 2007, she has served as a grant writer, manuscript editor, and project manager for many UC San Diego laboratories, assisting investigators involved in such diverse fields as hospital policy and quality improvement, radiology, medical physics, nanotechnology, materials science, and genomics. Ms Bass has also edited patient-education and complementary/alternative medicine guidebooks and newsletters for a San Diego-based health insurer. In addition to her academic degrees, in 2004 Ms Bass earned an Advanced Certificate in Technical & Scientific Writing from San Diego State University. Ms Bass joined the Edanz Group as an editor in 2011.

Dr Webster’s research has elucidated the biochemical and physiological mechanisms controlling the uptake and assimilation of free amino acids and the influence of Na+ and K+ ion gradients on these mechanisms. Since 1993, Dr Webster has been a Biomedical Indexer for Crossaig/Thomson and Derwent/Thomson Scientific. This work has included the therapeutic use of drugs, details of dosages and frequency of administration, drug comparisons and combinations, drug pharmacology and pharmacokinetic parameters, adverse effects/toxicity and treatment outcome. Dr Webster began working with Edanz Editing in 2006, editing in the fields of biological and environmental sciences.

Dr Daniel’s PhD thesis was entitled “Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90.” Dr Daniel is familiar with all standard laboratory and research techniques including molecular biological techniques, organ culture, tissue culture of immortalized cell lines (mammalian), recombinant production and purification of heterologous proteins, recombinant DNA manipulation, confocal fluorescent microscopy, transient transfection of mammalian cells, site directed mutagenesis, one- and two-dimensional gel electrophoresis, assay techniques, Western blot analysis and surface plasmon resonance spectroscopy, and thin layer and high pressure liquid chromatography (HPLC). Dr Daniel began as an editor with the Edanz Group in 2008.

Ms Kardashyan's honors project was “Neuronal apoptosis and mitochondrial function in striatal GABAergic neurons: mechanistic insights into Huntington’s disease.” From 2005 to 2008, she was a research assistant at the Howard Florey Institute, University of Melbourne, where she investigated the effects of preconditioning with hypoxia and hypoxia-mimetic compounds in neonatal rat brain with hypoxic-ischemic injury. She has also worked in the field of neurogenesis. Ms Kardashyan began working as an editor with the Edanz Group in 2008.

Mr Art Riddle has over 10 years of experience in neuroscience research and writing and is currently in the final stages of his MD/PhD. His research has focused on neuro-development and mechanisms of neurological injury. He has performed studies on neurotoxicology and experience-dependent plasticity in the developing rodent. For his doctoral research Mr Riddle is studying glial injury in small and preclinical animal models of hypoxic-ischemic preterm brain injury. In his studies he has become technically proficient in immunohistochemistry, slice culture, primary-cell culture, immunoblotting, protein purification, animal surgery, animal physiology, blood flow measurement, light/fluorescence/confocal microscopy, medical imaging and high-field magnetic resonance imaging. Mr Riddle is trained as a clinician and is familiar with human anatomy, biochemistry, physiology, pharmacology and epidemiology. He has written numerous peer-reviewed articles published in the Journal of Neuroscience, Journal of Child Neurology, Journal of Cerebral Blood Flow and Metabolism, and Stroke. He also has experience as a scientific writer in a range of topics including cerebral palsy, neurodegeneration, neurotoxicology, gliosis and cerebral blood flow. Art Riddle began working with the Edanz Group in 2009.

Mr Wallace’s background is in biochemistry and genetics. Later he focused on biomedical science/bioengineering, in particular nerve regeneration in both the peripheral and central nervous systems. His PhD focuses on tissue engineering for spinal cord injury and combines the use of novel nerve guides as cell carriers for the promotion of axonal regeneration. This project also looks at optimal cell isolation protocols for neural stem cells and optimization of nerve conduits using hydrogels. He is experienced in tissue extraction and cell culture, viral transduction, electrospinning, scanning electron microscopy, fluorescence microscopy, freeze-dry processing of scaffolds, collagen isolation, RT-PCR, SDS-PAGE, Southern blotting and histology. He has also worked as a Scientific Information Specialist for Thomson Scientific & Healthcare during 2004–2006. In this position he was responsible for analyzing and extracting information from life science and biomedical articles to allow for seamless access to current and retrospective multidisciplinary information from approximately 8,700 high-impact research journals from the Web of Science. He also worked as part of the quality control team for BIOSIS Previews, where he was required to write abstracts for scientific articles. Mr Wallace began working as an editor for the Edanz Group in 2009.